06078 HYGEIA HEALTH
- 23.950
- +0.900+3.90%
HYGEIA HEALTH News
Hong Kong Stock Market Changes | Hygeia Health (06078) is up more than 4% now, new acquisition of hospital contributes to performance. Nomura expects to achieve record high first-half results.
Hygeia Health (06078) has risen over 4% and as of press time, it rose 3.58% to HK$27.5 with a turnover of HK$17.4431 million.
Nomura Adjusts Hygeia Healthcare's Price Target to HK$50.70 From HK$58.20, Keeps at Buy
Nomura: Maintains a 'buy' rating for Hygeia Health (06078) and lowers the target price to HKD 50.7.
Nomura has lowered its revenue forecasts for Hygeia Health for the next two years by 3.3% and 5.5% respectively.
The Recent 3.3% Gain Must Have Brightened CEO Yiwen Zhu's Week, Hygeia Healthcare Holdings Co., Limited's (HKG:6078) Most Bullish Insider
Soochow Securities: "Implementation Plan for Supporting the Development of Innovative Drugs Across the Entire Chain" Approved, and the innovative drugs sector is expected to strengthen.
Soochow Securities released research reports stating that the specific provisions of the "Implementation Plan for Full-chain Support of Innovative Drug Development" are expected to be implemented soon. In addition, the innovative drug sector is currently at a historically relatively low level. In the second half of the year, there will be multiple catalysts such as the ESMO conference, WCLC conference, medical insurance negotiations, and expectations for the innovative drug sector going global, which may lead to a strong performance in the innovative drug sector.
Hygeia Health (06078.HK) received a shareholding of 728,600 shares from FIL Limited.
According to the latest equity disclosure information of the Stock Exchange, on June 20, 2024, hygeia health (06078.HK) received FIL Limited's shareholding of 728,600 shares at an average price of HK$30.3388 per share, involving about HK$22.105 million. After the shareholding, FIL Limited's latest number of shares held increased from 4.92% to 5.04%.
Hygeia Health was acquired by FIL Limited.
According to the documents disclosed by the Hong Kong Stock Exchange on the 26th, FIL Limited increased their shareholding in Hygeia Health (6078.HK) by purchasing 728,600 ordinary shares at an average price of HKD 30.3388 per share, with a total value of approximately HKD 22.1048 million on June 20th. After the company's increased shareholding, the latest shareholding quantity of FIL Limited is 31.8078 million shares, and the stake has increased from 4.92% to 5.04%.
Here's Why Shareholders May Want To Be Cautious With Increasing Hygeia Healthcare Holdings Co., Limited's (HKG:6078) CEO Pay Packet
Hygeia Healthcare Holdings (HKG:6078) Shareholders Will Want The ROCE Trajectory To Continue
[Brokerage Focus] Bocom Intl expects current high cost performance in medical sector, but industry sentiment has not fully recovered.
Jingu Finance Xintong | Bank of Communications International released the outlook for the pharmaceutical industry in the second half of 2024. They think that the pharmaceutical sector currently has high cost-effectiveness, but institutional positions have fallen to a low level and industry sentiment has not fully recovered. The bank recommends laying out three main themes in 2H24: 1) The Davis double-click opportunity of valuation bottoming out and performance rebounding; 2) Innovation is the theme of the industry's long-term development, taking into account the potential for product export; 3) Defensive opportunities with stable performance and high shareholder returns. The bank's preference ranking for segmented sectors is as follows: prescription drugs = innovative drugs > high dividend traditional Chinese medicine/circulation > private hospitals > CXO. Specifically, prescription drugs - performance growth rebound + valuation.
Are Robust Financials Driving The Recent Rally In Hygeia Healthcare Holdings Co., Limited's (HKG:6078) Stock?
After Leaping 28% Hygeia Healthcare Holdings Co., Limited (HKG:6078) Shares Are Not Flying Under The Radar
Here's Why Hygeia Healthcare Holdings (HKG:6078) Can Manage Its Debt Responsibly
HYGEIA HEALTH: ANNUAL REPORT 2023
China Post Securities: Endogenous growth is steady, and the Hong Kong stock healthcare services sector's valuation is highly attractive
Judging from the overall performance of medical service targets in Hong Kong stocks, with the exception of ICL's high revenue base in the early COVID-19 period, where dental revenue was affected by dental implant collection, most of the revenue from other medical service targets increased relatively well.
Hygea Healthcare (06078.HK) received 440,200 additional shares from Chairman and Executive Director Zhu Yiwen
Gelonghui, April 8 | According to the latest equity disclosure data of the Stock Exchange, on April 3, 2024, Hygea Healthcare (06078.HK) was granted an increase of 4402,000 shares at an average price of HK$29.54 per share on the market, involving approximately HK$13.35 million. After the increase in holdings, Zhu Yiwen's latest shareholding was 283,560,615 shares, and the shareholding ratio increased from 44.83% to 44.90%.
GF Securities: Target price of HK$38.81 for a “buy” rating for Hygea Healthcare (06078)
Zhitong Finance App learned that Guangfa Securities released a research report stating that according to the “buy” rating of Haijia Healthcare (06078), the net profit for 2024-26 is expected to be 9.0/11.4/1.43 billion yuan, respectively. Considering the scarcity of the company's private oncology medical services and the steady expansion of the business scale, the company was given a 24-year NongAAP net profit of 25x PE, with a corresponding reasonable value of HK$38.81 per share. The main points of the report are as follows: Hygea Healthcare announced 2023 full-year results. In 2023, the company achieved revenue of 4,077 billion yuan, +2 compared to the previous year
Hygeia Healthcare Holdings Co., Limited Just Missed Earnings - But Analysts Have Updated Their Models
Hygeia Healthcare's 2023 Profit Rises 42% on Higher Revenue; Shares Surge 15%
Changes in Hong Kong stocks | Hygea Healthcare (06078) rose more than 11%, and adjusted net profit increased 17.53% year-on-year last year, and the hospital business continued to grow healthily
Hygea Healthcare (06078) rose more than 11%. As of press release, it rose 10.46% to HK$29.05, with a turnover of HK$44.1561 million.
Analysis
Price Target
No Data
